Log in to save to my catalogue

Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized...

Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f2cc9bdd0cd344e49d5f119c751716d3

Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial

About this item

Full title

Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2022-06, Vol.13 (1), p.3654-3654, Article 3654

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

NVSI-06-08 is a potential broad-spectrum recombinant COVID-19 vaccine that integrates the antigens from multiple SARS-CoV-2 strains into a single immunogen. Here, we evaluate the safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in BBIBP-CorV recipients in a randomized, double-blind, controlled, phase 2 trial conducted in the U...

Alternative Titles

Full title

Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f2cc9bdd0cd344e49d5f119c751716d3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f2cc9bdd0cd344e49d5f119c751716d3

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-022-31379-0

How to access this item